Melphalan hydrochloride for injection may cause local tissue damage ... in the oral arm compared to the IV arm (P <.04). The IV melphalan arm had a higher incidence of severe myelotoxicity ...

On December 27, 2024, subcutaneous nivolumab (Opdivo Qvantig) was approved by the FDA in all previously approved adult solid ...